Greg Mattingly, MD, founding partner of St. Charles Psychiatric Associates in St. Louis, Missouri and Associate Clinical Professor of Psychiatry, Washington University.

Interview courtesy:   Supernus Pharmaceuticals
Website for more information:   Qelbree.com

Attention-Deficit/Hyperactivity Disorder (ADHD) is one of the most common psychiatric diagnoses in adults that affects ~1 in 16 adults and 1 in 10 children in the U.S. The condition is defined as a persistent pattern of inattention and/or hyperactivity-impulsivity that can interfere with daily life.

ADHD symptoms can include inattention (like struggling to pay attention or stay organized), hyperactivity (like being restless or talking excessively) and impulsivity (like interrupting or acting without thinking). However, ADHD symptoms aren’t always universal, especially when it comes to men and women. These symptoms can have a serious impact on those living with it and can lead to people having a hard time performing daily activities or fulfilling work responsibilities because of symptoms.

Despite ADHD being a 24/7 chronic disorder, there are options for those living with the condition to help manage symptoms, which can include a combination of behavioral management techniques as well as medication. When it comes to treatment options, there is no one-size-fits-all, and sometimes it takes trying several treatment options to figure out which works. For people with ADHD, the first step is in recognizing symptoms and having open and honest conversations with a trusted healthcare provider.

To shed light on ADHD during the awareness month, Dr. Mattingly is available for interviews to discuss how ADHD can present, various treatment options, and relevant data for doctor-patient conversations. He can also speak to:

What ADHD is and how it is known to affect the brain

How men and women may experience ADHD differently, plus symptoms that are often overlooked

Ways for managing symptoms, whether for the individual or their family and loved ones

The evolving ADHD treatment landscape and updated information on how one non-stimulant treatment option interacts with the body

The post ADHD Awareness Month in October Living with the Condition & What to Know About Evolving Treatments, NOT ONLY FOR YOUNG PEOPLE! appeared first on Good News!.

BIO:
Dr. Karsh earned his MD from The Chicago Medical School. He completed his General Surgical training at The University of Colorado Health Sciences Center and his Urology Residency at the Brigham and Women’s Hospital/Harvard Medical School.
Dr. Karsh was a co-founder of The Urology Center of Colorado which was recently acquired by Advent Health Urology Denver where he serves as an attending Urologist and Director of Research. He is a certified principal investigator with an experience of more than 275 clinical trials. Dr. Karsh has authored a number of peer-reviewed publications and serves on the editorial boards for “Bladder Cancer.” He is an active member of the AUA, , ASCO, BCAN, SUO,SWOG and the Denver Academy of Surgeons. Dr. Karsh served on the board of SUO from 2010-2020 and served on the bladder cancer subcommittee during that time.

Ferring Pharmaceuticals, Inc.

Website for more information:                           ADSTILADRIN

#cancer #bladdercancer #drkarsh #mike

The post BLADDER CANCER IS THE SIXTH MOST COMMON CANCER IN THIS COUNTRY? appeared first on Good News!.

Courtesy: Mirum Pharmaceuticals, Inc

#pspartners #mirum

The post Rare Disease Day is February 28thIT MAY BE AN “INVISIBLE ILLNESS” Yet One Major Symptom Remains Relentless Hear from Former NCAA All-American Hockey Player Who is Now a Hockey Coach appeared first on Good News!.

Although pain is one of the most common reasons that people visit the doctor, managing it can be complicated.

So, what’s a patient—or a doctor – to do?  Here to talk about the unmet need in treating acute pain is Dr. David Dalury, Professor of Orthopedic Surgery (Emeritus) at the University of Maryland.

vrtx.com 

The results show how patients’ lives are affected by acute pain:

70% say it limits them from walking and exercising.
69% says it limits their sleep.
65% says it affects their hobbies and leisure activities.
65% say it made them feel irritable or emotionally drained.
Patients reported missing an average of 19 working days annually.

Pain is one of the most common reasons that people visit the doctor; however, treatment options for the various types and causes of pain remain limited.i,ii,iii

Approximately 40 million Americans with acute pain are prescribed an opioid to manage their discomfort each year.vii Although opioids can be effective, they also carry a labeled risk of addiction.viii In fact, roughly 85,000 U.S. adults are expected to develop opioid use disorder (OUD) within a year of their prescribed treatment of acute pain.vii

Health care providers may prescribe either acetaminophen or nonsteroidal anti-inflammatory drugs (NSAIDs) as alternatives for milder pain or additions to opioids for severe acute pain; while these treatments are generally well tolerated, they may have limited effectiveness, particularly for moderate-to-severe acute pain.viii,ix

The survey also shows that:

77% of patients say they are interested in trying a different pain medication if they experience acute pain again.
52% say they are seeking a new pain medication with fewer side effects than their last medication.
31% say they stopped taking their medication before their pain was resolved.
On Wednesday, December 4th, Dr. David Dalury Professor of Orthopedic Surgery (Emeritus) at the University of Maryland will be available to discuss the survey results and help raise awareness about the unmet need in current pain management options and offer solutions.

Tell me about the State of Pain survey. What did it evaluate?​

Can you tell us some of the key findings? What did you learn? ​

Why is it important to focus on pain management right now? ​

Where can people learn more about the State of Pain survey?​

Interview is courtesy: Vertex Pharmaceuticals

#drdaviddalury #vertexpharmaceuticals #pain #orthopedicsurgery

The post NEW SURVEY ON PAIN SHOWS HOW IT DISRUPTS EVERYDAY LIFE & WHY THERE’S A NEED FOR ALTERNATIVE TREATMENTS appeared first on Good News!.

C. difficile infection (C. diff infection) is a highly contagious bacterial infection that causes half a million illnesses and tens of thousands of deaths in the U.S. each year. Yet, few people know what it is and how it occurs, despite being declared a public health threat by the U.S. Centers for Disease Control and Prevention (CDC).1-3

C. diff infection causes debilitating symptoms such as severe diarrhea, fever, stomach pain, loss of appetite, nausea and colitis.1 This infection can happen to anyone, at any age, and can be contracted in some of the most common places in the community and in hospitals.4-6 When the infection strikes, it can have a devastating impact on everyday life, including taking care of loved ones, going to work regularly and carrying out typical activities. And C. diff infection can come back – known as a recurrence.

Antibiotics – the current standard of care for treatment of C. diff infection – treat the disease but also can be a contributing factor to the cycle of recurrence.1,7 It has been estimated that up to 35% of C. diff infection cases can recur after the initial diagnosis8-11, and after first recurrence up to 65% may develop a subsequent recurrence.11,12

Recently, the FDA approved a first-of-its-kind microbiome-based treatment to prevent recurrent C. diff infection after completing antibiotics for recurrent C. diff infection.

Paul Feuerstadt, M.D., Yale University School of Medicine, will discuss:
• What is C. diff infection and who is vulnerable to contracting it
• Why does this infection recur and what are the consequences of recurrence
• What are the treatment options for recurrent C. diff infection
• How has the newest FDA-approved treatment changed how recurrent C. diff infection may be treated

Patricia, who suffered from recurrent C. diff infection, will share her personal story of her struggle with the infection, how it impacted her life and how she broke the cycle of recurrence.
Footnotes available on request

Courtesy: Ferring Pharmaceuticals
www.REBYOTA.com

Interview is courtesy of Ferring Pharmaceuticals

The post A DEVASTATING DISEASE YOU MAY NEVER HAVE HEARD OF BUT YOU SHOULD KNOW ABOUT: C. DIFFICILE INFECTION appeared first on Good News!.

Sometimes people must face the toughest opponents in life —and for approximately 30 million Americans with known heart disease, bad cholesterol is a formidable challenger. 1-3

Lowering bad cholesterol and keeping it low takes a solid game plan. With September marking the kick-off of the football season and National Cholesterol Education Month, it’s the perfect time for people to check in with their doctor to make sure they have all the right plays to manage their bad cholesterol.

The most common type of heart disease, called known heart disease, is caused by consistent high levels of bad cholesterol (LDL-C), fats and other substances in the blood, that leads to the buildup of plaque on the walls of the arteries.4 This buildup can lead to major cardiac events, like a heart attack or stroke, and blockages in the arteries causing chest pain.4 That’s why it’s important for people with known heart disease to lower bad cholesterol and keep it low; yet even with what may seem to be the best game plan, only 20 percent of people with known heart disease who take statins to lower their bad cholesterol achieve their recommended cholesterol goal.1

Tactics to defeat a tough opponent need to be constantly assessed and adjusted to help ensure success – and the same is true for managing bad cholesterol. While you can’t control factors like genetics or age, there are still ways you can find success with the right lifestyle modifications and working with your doctor the find the right treatment plan.

Dr. Boone, President, CEO, and Medical Director of the Boone Heart Institute to discuss what plays your viewers or listeners should incorporate into their game plan to help maintain their heart health this National Cholesterol Education Month and beyond. He will talk about the importance of cholesterol management, ways to lower it, and have details about a first of its kind treatment approved by the FDA to lower bad cholesterol.

Interview is courtesy: Novartis Pharmaceuticals Corporation

Sources:

1 Wong ND et al. Prevalence of the American College of Cardiology/American Heart Association stat ineligibility groups, statin use, and low-density lipoprotein cholesterol control in US adults using the National Health and Nutrition Examination Survey 2011–2012. J Clin Lipidol. 2016;10(5):1109-1118.

2 Selvin E, Alan TH. Contemporary Risk Factor Control and Walking Dysfunction in Individuals with Peripheral Arterial Disease: NHANES 1999-2004. Atherosclerosis. 2008; 201(2): 425–433.

3 Benjamin EJ et al. Heart Disease and Stroke Statistics— 2019 Update Report From the American Heart Association. Circulation. 2019;139(10):e56-e528.

4 Mayo Clinic. Arteriosclerosis / atherosclerosis. Accessed September 28, 2021: https://www.mayoclinic.org/diseases-conditions/arteriosclerosis-atherosclerosis/symptoms-causes/syc-20350569?p=1

#footballseason #highcholesterol #education #heartdisease #badcholesteral #doctor #managefats #blood #arteries #gameplan #tactics #drboone #medical #novartispharmaceuticals #fda

The post With Football Season Kicking Off TIME FOR YOU TO TACKLE YOUR HIGH CHOLESTEROL appeared first on Good News!.

www.vascularcures.org

When most people think of heart disease, their association is with coronary artery disease (CAD), where fatty deposits and plaque can build up in the arteries that carry blood from your heart through the body. But artery disease can affect more than just the heart. The limited blood flow caused by artery disease can be dangerous, leading to blood clots and a lesser known but very serious disease called peripheral artery disease (PAD).

CAD is the most common type of heart disease and is the greatest cause of morbidity and mortality in the U.S.1 Approximately 18.2 million adults over age 20 are living with CAD in the U.S.2 PAD affects an estimated 20 million Americans,3 yet only approximately 8.5 million are diagnosed.4 If left untreated, CAD and PAD can increase the risk of serious health outcomes such as heart attack, stroke,5 and – in the case of PAD – acute limb ischemia or even a lower limb amputation.6

It’s important to be aware of the potential connection between these two artery diseases. If you have CAD, you may have an increased risk of PAD – and vice versa.6 In fact, more than 40% of individuals with CAD also have PAD.1

Further, these conditions have overlapping risk factors – including hypertension (high blood pressure), diabetes and smoking (even formerly smoking).6 In fact, smoking is the most common preventable cause of PAD.7 Up to 90 percent of people with PAD have a history of smoking,8 and smokers have a 4x greater risk of PAD than nonsmokers.9

Early detection is key to reducing the chance of serious outcomes. Knowing your risk of CAD and PAD – and talking to your doctor – are important first steps.

Dr. Veita Bland, renowned hypertension specialist and family physician, and Pamela Parker, PAD patient and passionate advocate for artery disease awareness, discusses the importance of early detection, intervention and management of CAD and PAD.

Interview courtesy: Janssen Pharmaceuticals, Inc

IT’S HEARTHEALTH MONTH AND AN IMPORTANT TIME TO TALK ABOUT ARTERY DISEASE.

[ALT, if live or airing before February 1: HEART HEALTH MONTH IS JUST AROUND THE CORNER AND IT’S ANIMPORTANT TIME TO TALK ABOUT ARTERY DISEASE.]

ARTERY DISEASECAN AFFECT MORE THAN JUST YOUR HEART AND EARLY DETECTION IS KEY TO REDUCING THECHANCE OF SERIOUS OUTCOMES.

HERE TO TALKABOUT WHAT YOU NEED TO KNOW ABOUT CORONARY ARTERY DISEASE (C-A-D) AND A RELATEDCONDITION, CALLED PERIPHERAL ARTERY DISEASE (P-A-D), ARE FAMILY PHYSICIAN ANDRENOWNED HYPERTENSION SPECIALIST, DR. VEITA (“Veeta”) BLAND, ALONG WITH P-A-DPATIENT AND ADVOCATE, PAMELA.

BIO’S:

Dr. Veita Bland, Family Physician and Renowned Hypertension Specialist

Dr. Veita Bland is a practicing physician in Greensboro, North Carolina. She is a graduate of Bennett College, Temple University School of Medicine, and the residency program at The University of Maryland. She is board certified in Family Medicine and is a Certified Clinical Hypertension Specialist.

She has spent her career making sure her patients are informed about their health so they understand why taking care of their health is important and can pass down the correct information about their disease to others.

To that end, she is a columnist of medical articles for papers across the country and is the host of the nationally syndicated podcast, “It’s A Matter of Your Health: The30 Min Health Magazine”.

She believes that we all teach each other. So let’s get the information right.

Pam, PAD Patient and Advocate

Pam is a Health and Physical Education Educator in Washington D.C.’s public school system, a heart attack survivor, and a Champion of Women Heart, a non-profit organization that seeks to improve the health and quality of life of women living with or at risk of heart disease.

Pam has educated and empowered others for more than 25 years. She has consistently earned the ranking of Highly Effective Teacher and this year she was honored to be a Physical Education Emerging Leaders (PEEL) Fellowship Candidate. The fellowship builds teacher capacity and establishes schools that serve as a district-wide model of implementing a successful Health and Physical Education program amongst D.C. public schools.

Pam was diagnosed with PAD in 2009, which included immediate surgery to clear blockages in her legs, and suffered a heart attack in 2014. Her experiences led her to advocate in the heart health space. She is passionate about equipping youth –and all of us – with the knowledge and tools to make smart, healthy decisions. Presently, Pam is in the process of writing a children’s book, titled, “I Love My Heart”.

Pam has shared her experiences with Good Morning Washington in 2018 as well as the U.S. House of Representative in 2019. She has spoken at briefings on Capitol Hill, a panel with Vascular Cures and other events engaging lawmakers to inform future health policy.

#veita #bland #pam #vascular #cures #vascularcures #artery #disease #heart #coronary #peripheral #cad #pad #fatty #plaque #blood #diagnosed #janssen #pharmaceuticals #detection

The post Artery Disease Can Affect More Than Just Your Heart appeared first on Good News!.

ASCVD is a type of heart disease caused by consistent high levels of bad cholesterol (LDL-C) in the blood that leads to the buildup of plaque on the walls of the arteries. The plaque buildup results in problems such as heart attack and stroke. For people with ASCVD, also referred to as “known heart disease,” it’s important to lower bad cholesterol.
At the same time, many ASCVD patients struggle to lower their bad cholesterol, no matter how hard they try. For people with high cholesterol, it can be challenging to follow a strict diet, exercise and medication routine, when faced with the realities of day-to-day life.
And even when taking statins, the most commonly prescribed treatment for lowering cholesterol, up to 80% of patients with ASCVD aren’t meeting their cholesterol target. Furthermore, up to two-thirds of patients stop taking statins within one year of starting treatment.
There have been recent options available in treating the millions of patients with ASCVD who are not getting their cholesterol low enough and keeping it low. Seth J. Baum, MD, cardiologist and Chief Medical Officer of Excel Medical Clinical Trials, will be available to discuss ways to keep your heart healthy and a new available treatment option.
Interview courtesy: Novartis Pharmaceuticals Corporation

#heart #month #healthy #habits #cholesterol #seth #baum #cardiologist #medical #novartis #pharmaceuticals #corporation #leqvio #disease #atherosclerotic #cardiovascular #ascvd #ldl #stroke #attack

The post February is Heart Month CREATING HEART-HEALTHY HABITS Ways to Lower “Bad Cholesterol When Your Best Isn’t Enough” appeared first on Good News!.

Website for more information:
Spravato.com

In fact, depression is the leading cause of disability in the world, with an estimated 17.3 million American adults experiencing at least one major depressive episode in the past year.1,2

What’s more – one-third of people in the U.S. with MDD have treatment-resistant depression (TRD), meaning they have not responded adequately to at least two different antidepressants of adequate dose and duration in the current depressive episode.3,4

If you or someone you know are living with depression, now is an important time to check in and make sure the right care plan is in place. If symptoms persist after trying several treatment options, a discussion with a doctor may be needed to determine whether it’s MDD or TRD.

Craig Chepke, MD, will be available to discuss the signs of challenging to treat depression and the treatment options currently available. He will be joined by Sally, a patient living with TRD who is currently taking SPRAVATO® (esketamine) CIII nasal spray to help treat her depressive symptoms.

Interview is courtesy: Janssen Pharmaceuticals, Inc.

#holiday #blues #clinical #depression #mdd #major #depressive #disorder #negative #impact #life #spravato #disability #treatment #trd #resistant #craig #chepke #janssen #pharmaceuticals

The post Just the Holiday Blues…Or Is it? Learn effective ways to recognize appeared first on Good News!.

Why it’s so critical for the healthcare industry to dedicate energy to SCLC

Advice for those who are beginning their journey with SCLC

Support services that can improve psychosocial health and well-being

Montessa and Abizer will also share details about a new online program called Nothing Small About It, the first-ever digital hub dedicated solely to SCLC patients and their caregivers that aims to provide empathy, education and inspiration through a collection of intimate testimonials from people living with the disease and those who help provide support to them.

It was developed to meet people exactly where they’re at in their individual care journeys, and it is focused exclusively on the psychosocial and educational needs of all people living with this rare form of cancer.

Interview is courtesy: Jazz Pharmaceuticals

1 National Organization for Rare Diseases. Small cell lung cancer. https://rarediseases.org/rarediseases/small-cell-lung-cancer/. Updated 2019. Accessed March 11, 2021.
2 Figg WD, Smith EK, Price DK, et al. Disclosing a diagnosis of cancer: Where and how does it occur? J. Clin. Oncol. 2010 Aug 1;28(22):3630-3635

#lung #cancer #montessa #sclc #abizer #gaslightwala #small #cell #medical #stigma #fear #hopelessness #healthcare #physicians #nurses #scientists #researchers #disease #jazz #pharmaceuticals

The post November is Lung Cancer Awareness Month WORST FEARS SURROUNDING SMALL CELL LUNG CANCER appeared first on Good News!.